HotCopper on MSN3d
'Maximising the potential': Neurizon prepares for HEALEY study of ALS
Neurizon Therapeutics (ASX:NUZ) has shared an update on its preparations for its HEALEY ALS Platform Trial – a multicentre, double-blind, adaptive study that will assess the safety and efficacy of ...
US band confirm themselves for Glastonbury despite no official announcement from festival
Their tour poster, which includes stops in Europe, the US, and Canada, included a clearly marked Glastonbury slot on June 28.